Photo courtesy: The Indian Express
New Delhi: Eminent Indian virologist, Gagandeep Kang is skeptical about the Centre’s claim that it will get over 2 billion doses of vaccine from August to December. The production capacity of vaccine makers such as Serum Institute and Bharat Biotech is yet to ramp up, she said.
There is also no sufficient data to show the efficacy of Bharat Biotech’s nasal vaccine and Zydus Cadila’s DNA vaccine, she told Moneycontrol in an exclusive interview.
“I take the projections with a grain of salt. If you remember, last year, we were told that, by December, Serum Institute would produce 100 million doses of vaccine and Bharat Biotech in tens of millions of doses. There was going to be a large stockpile that was available with them. As we have found, that is not the case,” Kang told Moneycontrol.
It may be recalled that some states have floated global tenders for procuring a total of 121 million vaccine doses.
New Delhi: The Indian Computer Emergency Response Team (CERT-In) has issued a high-risk alert for… Read More
Cuttack: Fans, who queued up for as long as 14 hours to grab offline tickets… Read More
Bhubaneswar: The Bali Jatra in Odisha’s Cuttack has not received national status so far as… Read More
Bhubaneswar: The Odisha Vigilance on Friday arrested Malkangiri Watershed deputy director Santanu Mohapatra and four… Read More
Prayagraj: A fire broke out at a camp in Maha Kumbh Nagar in Uttar Pradesh’s… Read More
Mumbai: The will of Ratan Tata has sprung a surprise with Mohini Mohan Dutta, a… Read More
This website uses cookies.